Refine
Has Fulltext
- yes (5)
Is part of the Bibliography
- yes (5)
Document Type
- Journal article (4)
- Doctoral Thesis (1)
Language
- English (5)
Keywords
- DNA nanotechnology (1)
- Fluoreszenzmikroskopie (1)
- Hochaufgelöste Fluoreszenzmikroskopie (1)
- Membrane receptor (1)
- Membranrezeptor (1)
- Super-resolution microscopy (1)
- T cells (1)
- actin (1)
- acute myeloid leukaemia (1)
- biology (1)
- cancer microenvironment (1)
- conformational restriction (1)
- cyanine dyes (1)
- fluorescent dyes (1)
- immunotherapy (1)
- phlorizin (1)
- single-molecule fluorescence spectroscopy (1)
- super-resolution microscopy (1)
- transportome (1)
- tumour immunology (1)
- volume regulation (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (5) (remove)
Immune checkpoint blockade therapy is beneficial and even curative for some cancer patients. However, the majority don’t respond to immune therapy. Across different tumor types, pre-existing T cell infiltrates predict response to checkpoint-based immunotherapy. Based on in vitro pharmacological studies, mouse models and analyses of human melanoma patients, we show that the cytokine GDF-15 impairs LFA-1/β2-integrin-mediated adhesion of T cells to activated endothelial cells, which is a pre-requisite of T cell extravasation. In melanoma patients, GDF-15 serum levels strongly correlate with failure of PD-1-based immune checkpoint blockade therapy. Neutralization of GDF-15 improves both T cell trafficking and therapy efficiency in murine tumor models. Thus GDF-15, beside its known role in cancer-related anorexia and cachexia, emerges as a regulator of T cell extravasation into the tumor microenvironment, which provides an even stronger rationale for therapeutic anti-GDF-15 antibody development.